Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy

Launched by NANCHONG CENTRAL HOSPITAL · Jun 13, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating whether using special patches to reinforce staplers during a surgery called gastrojejunostomy can reduce complications compared to standard staplers. This surgery is often performed on patients with gastric cancer who need part of their stomach removed. The goal is to see if these reinforcement patches can help prevent problems like leaks at the surgical connection and improve recovery after the operation.

To participate in this trial, you need to be between 18 and 85 years old and have been diagnosed with gastric cancer that allows for certain types of stomach surgery. You should be in good overall health, meaning you can perform normal daily activities without major issues. If you decide to join, you'll receive detailed information and support throughout the study. It's important to note that if you have certain serious health conditions or have participated in another clinical trial recently, you may not be eligible. This study is currently looking for volunteers, and your participation could contribute to better surgical outcomes for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 18 and 85 years.
• • Pathologically diagnosed with gastric cancer and suitable for distal gastrectomy or subtotal gastrectomy.
• • ECOG performance status of 0 or 1.
• • ASA (American Society of Anesthesiologists) classification of I-III.
• • Voluntary signed informed consent from the participant or their legal representative.
• Exclusion Criteria:
• • Evidence of potential distant metastasis found preoperatively.
• • History of other malignancies diagnosed within the past 5 years, or any malignancy treated with chemotherapy or radiotherapy.
• • Significant contraindications for surgery (e.g., severe liver or kidney dysfunction).
• • Participation in any other clinical trial within the last 6 months.
• • Participants or their legal representatives unwilling to sign the informed consent or comply with the study protocol.